Perbedaan UBC Medical Indonesia Tbk. dan Prodia Diagnostic Line Tbk: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Prodia Diagnostic Line Tbk diperdagangkan di Rp270 (kapitalisasi pasar 470,58 M, volume 24 jam 28,43 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan Prodia Diagnostic Line Tbk lebih aktif diperdagangkan (28,43 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | PRDL | |
|---|---|---|
Kapitalisasi Pasar | 635,95 M | 470,58 M |
Volume | 843 rb | 28,43 jt |
Lot | 8,43 rb | 284,34 rb |
Perputaran | 137,6 jt | 7,8 M |
Harga Rata-rata | 163,22 | 274,19 |
Nilai Transaksi | 137,6 jt | 7,8 M |
Harga Ekuilibrium Indikatif | 165 | 270 |
Volume Ekuilibrium Indikatif | 246 | 2,1 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Selengkapnya di halaman PRDL →